PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

British Patient Capital invests in Microbiotica

British Patient Capital has invested in Microbiotica, a personalised medicine specialist, as part of a GBP50 million Series B funding round.

The investment has been made via Future Fund: Breakthrough, British Patient Capital’s GBP375 million programme that makes co-investments with private sector investors in innovative, R&D-intensive UK companies. 

The round was led by Flerie Invest and Tencent, and included Cambridge Innovation Capital, IP Group and Seventure Partners.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured